Laura and Isaac Perlmutter Cancer Center — New York, New York

Public research footprint of Laura and Isaac Perlmutter Cancer Center, compiled from the ClinicalTrials.gov public registry.

439

Registered studies

249

Active

100

Recruiting now

142

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Dedifferentiated Carcinoma · Locally Advanced Malignant Solid Neoplasm · Metastatic Renal Cell Carcinoma · Endometrial Clear Cell Adenocarcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Laura and Isaac Perlmutter Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.